chr17-35997840-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_032965.6(CCL15):c.269G>A(p.Arg90Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,613,716 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_032965.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCL15 | NM_032965.6 | c.269G>A | p.Arg90Gln | missense_variant | 4/4 | ENST00000617897.2 | NP_116741.2 | |
CCL15-CCL14 | NR_027922.3 | n.815G>A | non_coding_transcript_exon_variant | 4/7 | ||||
CCL15-CCL14 | NR_027921.3 | n.815G>A | non_coding_transcript_exon_variant | 4/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCL15 | ENST00000617897.2 | c.269G>A | p.Arg90Gln | missense_variant | 4/4 | 1 | NM_032965.6 | ENSP00000484078 | P1 | |
CCL15 | ENST00000614368.1 | c.113G>A | p.Arg38Gln | missense_variant | 2/3 | 3 | ENSP00000484262 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152062Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 248964Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134772
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461654Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 727138
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152062Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74274
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 30, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at